ICON issues financial guidance for 2008 and reaffirms guidance for 2007. Read more about ICON issues financial guidance for 2008 and reaffirms guidance for 2007.
ICON increases Central and Eastern European presence Read more about ICON increases Central and Eastern European presence
ICON Development Solutions Signs Partnership With The Medicines Evaluation Unit Read more about ICON Development Solutions Signs Partnership With The Medicines Evaluation Unit
ICON Announces The Acquisition Of Healthcare Discoveries Inc Read more about ICON Announces The Acquisition Of Healthcare Discoveries Inc
ICON reports Full-Year 2007 revenue growth of 38% operating income growth of 45% and EPS growth of 41% (NASDAQ:ICLR) Read more about ICON reports Full-Year 2007 revenue growth of 38% operating income growth of 45% and EPS growth of 41% (NASDAQ:ICLR)
ICON team recognised for outstanding quality at PharmaTimes awards Read more about ICON team recognised for outstanding quality at PharmaTimes awards
ICON plc announce date and time for Q1 2008 Earnings Call Read more about ICON plc announce date and time for Q1 2008 Earnings Call
ICON Central Laboratories Enhances Scientific Services with New R&D Staff Read more about ICON Central Laboratories Enhances Scientific Services with New R&D Staff
ICON reports 48% increase in revenue and 46% increase in operating income and raises guidance for 2008 Read more about ICON reports 48% increase in revenue and 46% increase in operating income and raises guidance for 2008
ICON plc announces appointment of Professor Dermot Kelleher to the Board of Directors. Read more about ICON plc announces appointment of Professor Dermot Kelleher to the Board of Directors.